Video

Greatest Unmet Needs for Patients with Endometrial Cancer

Author(s):

Courtney R. Arn, APRN-CNPKimberly Halla, NP

The panel shares the most critical unmet needs for patients with endometrial cancer.

Related Videos
5 KOLs are featured in this program
5 KOLs are featured in this program
A panel of 4 experts on lung cancer
A panel of 4 experts on lung cancer
A panel of 5 experts on breast cancer
5 KOLs are featured in this peer exchange
A panel of 5 experts on breast cancer
5 KOLs are featured in this peer exchange
5 KOLs are featured in this panel.
5 KOLs are featured in this panel.
Related Content
FDA
July 3rd 2024

OncLive’s June Roundup of Key FDA Approvals in Oncology

Bradley J. Monk, MD, FACOG, FACS; Paolo Tarantino, MD
January 11th 2024

Monk and Tarantino Describe the Investigation of B7-H4 Vedotin–Directed ADCs in Gynecologic and Breast Cancers

Els Van Nieuwenhuysen, MD
July 1st 2024

Durvalumab Plus Olaparib Approaches EU Approval for pMMR Advanced or Recurrent Endometrial Cancer

R. Wendel Naumann, MD
October 26th 2023

Naumann Discusses Notable Research Efforts in Endometrial Cancer

Rebecca Kristeleit, BSc, MBChB, MRCP, PhD, a consultant medical oncologist and clinical senior lecturer in the Department of Oncology at the University College-London Cancer Institute in England
June 24th 2024

Rucaparib Maintenance Elicits Continued PFS Benefit Across Newly Diagnosed Ovarian Cancer Subgroups

Dostarlimab/Chemotherapy in Endometrial Cancer | Image Credit: © freshidea - stock.adobe.com
June 24th 2024

Dostarlimab/Chemotherapy Under EMA Review for Primary Advanced/Recurrent Endometrial Cancer